financetom
Business
financetom
/
Business
/
Rio Tinto Urged by Palliser Capital to Unify Dual-Listing Structure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rio Tinto Urged by Palliser Capital to Unify Dual-Listing Structure
Dec 4, 2024 4:42 AM

07:23 AM EST, 12/04/2024 (MT Newswires) -- Rio Tinto (RIO) on Wednesday was urged by activist investor Palliser Capital to unify its dual listed structure on the London and Australian stock exchanges into a single Australia-based holding company.

The investment firm, which said it holds a "significant" position in the mining company, said in a letter and presentation that the dual structure has destroyed about $50 billion in shareholder value by limiting the company's ability to pursue all-stock acquisitions and creating other inefficiencies.

"So compelling is the case for unification that every other large cap public company with a dual-listed company structure has already successfully unwound it, with overwhelming support from their directors and shareholders alike," the company said. "Every day that this archaic structure remains in place, shareholder losses continue to mount."

Palliser urged Rio Tinto's board to launch an independent review of a possible unification and publish a report for shareholders.

Rio Tinto did not immediately reply to MT Newswires' request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%
Apr 2, 2024
01:42 PM EDT, 04/02/2024 (MT Newswires) -- Telo Genomics ( TDSGF ) a biotech company developing a telomere technology platform with applications measuring genomic instability in oncology, reports that patient recruitment for its minimal residual disease (MRD) clinical trial have begun. MRD refers to cancer cells that remain in the patient's system post-treatment. So far, several patient samples have been...
Update: VirTra Shares Rise After Q4 Earnings, Revenue Climb
Update: VirTra Shares Rise After Q4 Earnings, Revenue Climb
Apr 2, 2024
01:36 PM EDT, 04/02/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.) VirTra ( VTSI ) shares rose 36% in recent Tuesday trading, a day after the company reported gains in Q4 earnings and revenue. Net income in the quarter ended Dec. 31 rose to $0.25 per diluted share from $0.13 a year earlier....
Simply Better Brands Provides Corporate Update, Suspends Operations of Purekana Subsidiary
Simply Better Brands Provides Corporate Update, Suspends Operations of Purekana Subsidiary
Apr 2, 2024
01:39 PM EDT, 04/02/2024 (MT Newswires) -- Simply Better Brands ( SBBCF ) shares were last seen up 7.2% after the company on Tuesday said operations of its 50.1% owned subsidiary, PureKana, LLC, are being suspended. According to a company statement, PureKana plans to commence bankruptcy proceedings under Chapter 7 of the Bankruptcy Code of the United States as soon...
Canoo Remains Cost Conscious Amid Capital Concerns, Wedbush Says
Canoo Remains Cost Conscious Amid Capital Concerns, Wedbush Says
Apr 2, 2024
01:40 PM EDT, 04/02/2024 (MT Newswires) -- Canoo ( GOEV ) has remained cost conscious amid concerns over its capital needs after the electric vehicles maker missed revenue expectations while beating consensus on the bottom line in Q4, Wedbush said in a report Tuesday. From a cost perspective, the company remains extremely cost conscious, lowering its overall R&D expense by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved